IXICO plc Stock

Equities

IXI

GB00BFXR4C20

Biotechnology & Medical Research

Market Closed - London S.E. 11:35:03 2024-04-17 am EDT 5-day change 1st Jan Change
8.75 GBX 0.00% Intraday chart for IXICO plc 0.00% -30.00%
Sales 2024 * 5.2M 6.47M Sales 2025 * - Capitalization 4.23M 5.27M
Net income 2024 * -2M -2.49M Net income 2025 * - EV / Sales 2024 * 0.54 x
Net cash position 2024 * 1.4M 1.74M Net cash position 2025 * - 0 EV / Sales 2025 * -
P/E ratio 2024 *
-1.59 x
P/E ratio 2025 *
-
Employees 89
Yield 2024 *
-
Yield 2025 *
-
Free-Float 52.5%
More Fundamentals * Assessed data
Dynamic Chart
Current month+8.02%
1 month+20.69%
3 months-30.00%
6 months-39.66%
Current year-30.00%
More quotes
1 week
8.50
Extreme 8.5
8.84
1 month
8.00
Extreme 8
9.00
Current year
6.35
Extreme 6.35
13.50
1 year
6.35
Extreme 6.35
21.00
3 years
6.35
Extreme 6.35
105.00
5 years
6.35
Extreme 6.35
127.00
10 years
6.35
Extreme 6.35
127.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 63 17-02-05
Director of Finance/CFO 47 19-05-30
Chairman 59 13-10-13
Members of the board TitleAgeSince
Chairman 59 13-10-13
Director/Board Member 48 16-09-15
Director/Board Member 60 23-10-04
More insiders
Date Price Change Volume
24-04-17 8.75 0.00% 56,574
24-04-16 8.75 0.00% 17,300
24-04-15 8.75 0.00% 7,427
24-04-12 8.75 0.00% 1,898
24-04-11 8.75 0.00% 4,250

Delayed Quote London S.E., April 17, 2024 at 11:35 am EDT

More quotes
IXICO plc is a United Kingdom-based company that provides specialist data analytics services to the global biopharmaceutical industry. The services include the collection, analysis, management, and reporting on data generated in the course of a clinical study. The outputs from the data analysis are used to enhance patient selection, monitor drug safety, and assess clinical efficacy of the drug under development. It offers a range of services, such as drug development analytics, imaging operations, post-marketing, and post-marketing. It offers end to end services, including trial design and consultation, project management, imaging site set-up and management, data management, reading and analysis, and regulatory pathway. It offers a range of clinical trial imaging analysis tools, including radiological reads, structural and advanced magnetic resonance imaging (MRI). Its specialist data analytics services identify and measure biomarkers from brain scans and wearable biosensors.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Annual profits - Rate of surprise